RVNC - Revance Therapeutics Inc. (RVNC) CEO Mark Foley on Q1 2020 Results - Earnings Call Transcript
Revance Therapeutics, Inc. (RVNC)
Q1 2020 Earnings Conference Call
May 07, 2020 04:30 PM ET
Company Participants
Jeanie Herbert - Senior Director of Investor Relations and Corporate Communications
Mark Foley - President and Chief Executive Officer
Toby Schilke - Chief Financial Officer
Dr. Abhay Joshi - Chief Operating Officer and President of R&D and Product Operations
Dustin Sjuts - Chief Commercial Officer of Aesthetics and Therapeutics
Conference Call Participants
Jacob Hughes - Wells Fargo Securities
Balaji Prasad - Barclays
Annabel Samimy - Stifel
Difei Yang - Mizuho Securities
Tim Lugo - William Blair
Seamus Fernandez